Department of Sleep Disorders and Neuroses, Brain Hospital of Hunan Province, Changsha, Hunan Province, China.
Department of Clinlical Psychology, Brain Hospital of Hunan Province, Changsha, Hunan Province, China.
Immun Inflamm Dis. 2022 Nov;10(11):e707. doi: 10.1002/iid3.707.
INTRODUCTION: n-3 polyunsaturated fatty acids (PUFAs) are believed to be implicated in the pathogenesis of many inflammation-related diseases, including depression. METHODS: The mouse model of depression was established through chronic unpredictable mild stress (CUMS), the mice were intervened with n-3 PUFAs, and then the expression of toll-like receptor 4 (TLR4) was stimulated with lipopolysaccharides (LPS). Tail suspension test (TST), forced swimming test (FST) and sucrose preference test were performed to monitor the depression behavior of mice. Microglia activation was detected by Iba1 immunofluorescence, and neuronal injury was detected by Nissl staining. Concentrations of tumor necrosis factor (TNF)-α, Interleukin (IL)-6 and IL-1β in the hippocampus were assessed via enzyme linked immunosorbent assay (ELISA). Quantitative real time polymerase chain reaction was used to detect IL-6, IL-1β and TNF-α messenger RNA levels. Western blot was utilized for detection of TLR4 protein expression. RESULTS: CUMS significantly reduced the sucrose preference in mice, while increased the immobility time in FST and TST. Moreover, CUMS significantly aggravated microglia activation and neuronal damage in mice and increased the levels of IL-6, IL-1β and TNF-α in hippocampal tissues, however, intervention with n-3 PUFAs could improve the above effects. Further, the increased TLR4 induced by LPS partially reversed the inhibition of n-3 PUFAs on depression-like behaviors, microglial activation and inflammatory injury of hippocampal neurons. CONCLUSION: n-3 PUFAs may ameliorate depression-like behaviors via reducing hippocampal neuroinflammation in CUMS-induced mice by regulating TLR4 expression, suggesting that n-3 PUFAs may be an effective antidepressant, which provides evidence for future treatment of depression.
简介:n-3 多不饱和脂肪酸(PUFAs)被认为与许多炎症相关疾病的发病机制有关,包括抑郁症。
方法:采用慢性不可预测轻度应激(CUMS)建立抑郁症小鼠模型,用 n-3 PUFAs 干预,用脂多糖(LPS)刺激 Toll 样受体 4(TLR4)表达。通过悬尾试验(TST)、强迫游泳试验(FST)和蔗糖偏好试验监测小鼠的抑郁行为。Iba1 免疫荧光检测小胶质细胞激活,尼氏染色检测神经元损伤。酶联免疫吸附试验(ELISA)检测海马组织肿瘤坏死因子(TNF)-α、白细胞介素(IL)-6 和 IL-1β浓度。实时定量聚合酶链反应(qRT-PCR)检测 IL-6、IL-1β 和 TNF-α信使 RNA 水平。Western blot 检测 TLR4 蛋白表达。
结果:CUMS 显著降低了小鼠的蔗糖偏好,增加了 FST 和 TST 的不动时间。此外,CUMS 显著加重了小鼠小胶质细胞激活和神经元损伤,并增加了海马组织中 IL-6、IL-1β 和 TNF-α的水平,而 n-3 PUFAs 的干预可以改善上述效应。进一步的研究表明,LPS 诱导的 TLR4 增加部分逆转了 n-3 PUFAs 对抑郁样行为、海马神经元小胶质细胞激活和炎症损伤的抑制作用。
结论:n-3 PUFAs 通过调节 TLR4 表达减轻 CUMS 诱导的小鼠海马神经炎症,可能改善抑郁样行为,提示 n-3 PUFAs 可能是一种有效的抗抑郁药,为未来治疗抑郁症提供了依据。
Molecules. 2019-1-17
World J Psychiatry. 2025-5-19
Curr Issues Mol Biol. 2025-1-27
Womens Health Rep (New Rochelle). 2024-12-6
Int J Mol Sci. 2024-5-7
Antioxidants (Basel). 2023-3-16
Int J Mol Sci. 2022-4-29
Curr Neuropharmacol. 2021
Transl Psychiatry. 2019-8-5